The elevated level of Del-1 in circulating exosomes of breast cancer patients (p < 0.0001) yielded an outstanding diagnostic performance in differentiating early-stage breast cancer patients from the controls [100]. This evidence concerns the gene EDIL3 and breast carcinoma.